Skip to main content

Table 4 Effects of curcumin and/or coenzyme Q10 supplementation on lipid profile and body compositiona

From: Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial

Variables

CP group

(n = 22)

QP group

(n = 22)

CQ group

(n = 22)

DP group

(n = 22)

Pbaseline

Pbetween groups

Lipid profileb

 TC, mg/dL

0.52

<  0.001

  Week 0

217.4 ± 37.4

238.4 ± 37.9

228.2 ± 47.9

238.4 ± 68.1

  Week 12

186.5 ± 30.4

228.3 ± 39.8

221.2 ± 40.7

237.7 ± 53.9

  Mean difference

−30.9 ± 35.1

−10.1 ± 30.2

−7.0 ± 36.3

−0.7 ± 43.4

  Pwithin groups

< 0.001

0.06

0.15

0.70

 LDL-c, mg/dL

0.46

< 0.001

  Week 0

89.4 ± 6.5

90.8 ± 8.6

96.3 ± 11.2

89.3 ± 10.1

  Week 12

75.3 ± 5.4

88.5 ± 8.4

95.3 ± 11.4

87.3 ± 7.4

  Mean difference

−14.1 ± 6.2

−2.3 ± 8.3

−1.0 ± 9.3

−2.0 ± 8.4

  Pwithin groups

< 0.001

0.35

0.42

0.40

Body composition indicesc

 Weight, Kg

0.07

0.19

  Week 0

92.1 ± 8.2

94.0 ± 10.1

91.0 ± 10.8

92.1 ± 10.5

  Week 12

90.1 ± 8.1

92.2 ± 15.8

89.1 ± 10.2

91.1 ± 10.1

  Mean difference

−2.0 ± 7.6

−1.8 ± 12.6

−1.9 ± 9.7

−1.0 ± 9.5

  Pwithin groups

0.07

0.09

0.08

0.15

 BMI, Kg/m2

0.21

0.45

  Week 0

30.0 ± 4.6

30.7 ± 4.9

29.7 ± 5.1

30.0 ± 4.7

  Week 12

29.4 ± 4.2

30.1 ± 5.6

29.1 ± 5.0

29.7 ± 4.7

  Mean difference

−0.6 ± 3.9

−0.6 ± 4.5

−0.6 ± 4.5

−0.3 ± 4.4

  Pwithin groups

0.34

0.41

0.40

0.45

  1. CP curcumin plus placebo, QP coenzyme Q10 plus placebo, CQ curcumin plus coenzyme Q10, DP double placebo, TC total cholesterol, LDL-c low density lipoprotein-cholesterol, BMI body mass index, TG triglyceride, HDL-c high density lipoprotein-cholesterol, WC waist circumference
  2. aData are expressed as mean ± standard deviation (SD). bValues of TG and HDL-c, which are parameters of lipid profile, are expressed in Table 2. cValues of WC, which is a variable of body composition, is expressed in Table 2